Terms: = Lymphoma AND KMT2D, ENSG00000167548, 8085, MLL2 AND Prognosis
49 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of the feasibility and prognostic value of circulating tumor DNA monitoring in detecting gene mutations in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy].
Zhou LH; Feng YQ; Hu YX; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):805-812. PubMed ID: 38049331
[No Abstract] [Full Text] [Related]
3. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence.
Wu G; Yoshida N; Liu J; Zhang X; Xiong Y; Heavican-Foral TB; Mandato E; Liu H; Nelson GM; Yang L; Chen R; Donovan KA; Jones MK; Roshal M; Zhang Y; Xu R; Nirmal AJ; Jain S; Leahy C; Jones KL; Stevenson KE; Galasso N; Ganesan N; Chang T; Wu WC; Louissaint A; Debaize L; Yoon H; Dal Cin P; Chan WC; Ho Sui SJ; Ng SY; Feldman AL; Horwitz SM; Adelman K; Fischer ES; Chen CW; Weinstock DM; Brown M
Sci Transl Med; 2023 Sep; 15(714):eadi7244. PubMed ID: 37729434
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma.
Sung HJ; Kim D; Yoon DH; Cho H; Huh J; Suh CW; Go H
Hum Pathol; 2023 Sep; 139():106-116. PubMed ID: 37517597
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics of Molecular Genetic Mutations and Their Correlation with prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
7. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
8. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
9. Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
Lv L; Qi X; Wang C; Ma Y; Nie Y; Abulaiti R; Zhang F; Shi Q; Kou Z; Abuduer M; Zhai S; An L; Huang Q; Gu Z; Ou Q; Liu H; Wang Z; Shao Y; Sun Z; Fu L; Wang X; Mao M; Li Y
Clin Exp Med; 2023 Oct; 23(6):2675-2685. PubMed ID: 36811800
[TBL] [Abstract] [Full Text] [Related]
10. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Profiling of Diffuse Large B-Cell lymphoma: A Comparison Between Double-Expressor lymphoma and Non-Double-Expressor lymphoma.
Chen H; Qin Y; Liu P; Yang J; Gui L; He X; Zhang C; Zhou S; Zhou L; Yang S; Shi Y
Mol Diagn Ther; 2023 Jan; 27(1):75-86. PubMed ID: 36401148
[TBL] [Abstract] [Full Text] [Related]
12. Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with kmt2d and MECOM mutations.
Wang L; Tang J; Feng J; Huang Y; Cheng Y; Xu H; Miao Y
Front Immunol; 2022; 13():1001482. PubMed ID: 36325357
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
[TBL] [Abstract] [Full Text] [Related]
14. A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Wang X; Hong Y; Meng S; Gong W; Ren T; Zhang T; Liu X; Li L; Qiu L; Qian Z; Zhou S; Zhao M; Zhai Q; Meng B; Ren X; Zhang H; Wang X
Clin Immunol; 2022 Oct; 243():109105. PubMed ID: 36055572
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Mutation Landscape of Primary Breast lymphoma: Next-Generation Sequencing Analysis.
Zhang W; Huang C; Liu J; Wu L; Zhang H; Wu X; Wang L; Li W; Liu W; Liu L
Dis Markers; 2022; 2022():6441139. PubMed ID: 35937947
[TBL] [Abstract] [Full Text] [Related]
16. USP7 sustains an active epigenetic program via stabilizing mll2 and WDR5 in diffuse large B-cell lymphoma.
Wu Y; Gu H; Bao Y; Lin T; Wang Z; Gu D; Shen H; Xian H; Fan Y; Mao R
Cell Biochem Funct; 2022 Jun; 40(4):379-390. PubMed ID: 35411950
[TBL] [Abstract] [Full Text] [Related]
17. High grade B-cell lymphoma with
Ferrari A; Arniani S; Crescenzi B; Ascani S; Flenghi L; Pierini V; Moretti M; Beacci D; Romoli S; Bardelli V; Calistri D; Martinelli G; Mecucci C; La Starza R
Leuk Lymphoma; 2022 Jun; 63(6):1356-1362. PubMed ID: 35045798
[TBL] [Abstract] [Full Text] [Related]
18. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
[TBL] [Abstract] [Full Text] [Related]
19. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell lymphoma.
Mu S; Shi D; Ai L; Fan F; Peng F; Sun C; Hu Y
Front Immunol; 2021; 12():732006. PubMed ID: 34745101
[TBL] [Abstract] [Full Text] [Related]
20. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
[TBL] [Abstract] [Full Text] [Related]
[Next]
